Gsa Capital Partners LLP Accelerate Diagnostics, Inc Transaction History

Gsa Capital Partners LLP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.51 - $17.1 $253,830 - $8.51 Million	497,706 Added 412.36%	618,402 $437,000
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $121,902 - $2.05 Million	120,696 New	120,696 $183,000
Q2 2022 Aug 09, 2022	SELL	$0.54 - $1.41 $87,523 - $228,534	-162,081 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$1.4 - $5.15 $152,936 - $562,586	109,240 Added 206.73%	162,081 $233,000
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $106,468 - $173,789	24,934 Added 89.35%	52,841 $276,000
Q3 2021 Nov 12, 2021	BUY	$5.31 - $8.25 $148,186 - $230,232	27,907 New	27,907 $163,000
Q2 2021 Aug 05, 2021	SELL	$6.81 - $9.23 $93,780 - $127,106	-13,771 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$7.99 - $15.0 $393,004 - $737,805	-49,187 Reduced 78.13%	13,771 $115,000
Q4 2020 Feb 03, 2021	BUY	$7.04 - $11.7 $443,224 - $736,608	62,958 New	62,958 $477,000
Q3 2020 Nov 06, 2020	SELL	$9.98 - $18.04 $154,789 - $279,800	-15,510 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$7.49 - $15.16 $116,169 - $235,131	15,510 New	15,510 $235,000
Q3 2018 Nov 13, 2018	SELL	$20.4 - $24.6 $448,799 - $541,200	-22,000 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$19.02 - $24.95 $483,108 - $633,730	-25,400 Reduced 53.59%	22,000 $491,000
Q1 2018 May 11, 2018	BUY	$22.55 - $29.9 $446,490 - $592,020	19,800 Added 71.74%	47,400 $1.08 Million
Q4 2017 Feb 14, 2018	SELL	$18.0 - $30.0 $496,800 - $828,000	-27,600 Reduced 50.0%	27,600 $723,000
Q3 2017 Nov 20, 2017	BUY	$21.1 - $25.15 $1.16 Million - $1.39 Million	55,200	55,200 $1.24 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.